Navigation Links
Valeant Pharmaceuticals Reports 2012 Third Quarter Financial Results
Date:11/2/2012

million, respectively.(i)  Total Acquired IPR&D for the nine months ended September 30, 2012 of $149.9 million is primarily the write-off of the IPR&D asset related to the IDP-107 dermatology program, $133.4 million, a $12.0 million payment to terminate a research and development commitment with a third party, and $4.3 million related to the termination of the MC5 program acquired from Ortho Dermatologics.  Total Acquired IPR&D for the nine months ended September 30, 2011 of $4.0 million relates to the acquisition of the Canadian rights to Lodalis TM.(j) For the nine months ended September 30, 2012 Legal settlement costs of $56.8 million primarily relate to the litigation settlement and associated legal fees with respect to a class action antitrust complaint regarding Wellbutrin XL ®.(k) Restructuring, acquisition-related and other costs of $161.2 million represent costs related to the acquisitions of Sanitas, Afexa, Ortho Dermatologics, Dermik, iNova, Probiotica, Eyetech, OraPharma, University Medical, Gerot Lannach, Atlantis, Swiss Herbal, and Pedinol as well as other internal restructuring and integration initiatives.
These include $26.0 million related to acquisition costs, $46.4 million related to employee severance costs, $46.6 million related to integration consulting, duplicative labor, and transition services, $27.5 million related to facility closure costs, $10.7 million related to other, and $4.0 million related to non-personnel manufacturing integration costs.(l) Restructuring, acquisition-related and other costs of $73.9 million represent costs related to the merger of Legacy Valeant into Legacy Biovail and the acquisitions of PharmaSwiss SA and Sanitas.  These costs include $18.0 million related to facility closure costs, $24.3 million related to contract cancellation fees, consulting, legal and other costs, $14.3 million related to severance, $12.9 million related to acquisition costs, and $4.4 million re
'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) today reported ... the three and six months ended June 30, 2015, ... and $43.4 million for the same periods in 2014. ... the more than $90 million of revenue Isis earned ... from Bayer to license  ISIS-FXI Rx .  Isis increased ...
(Date:8/4/2015)... -- Intec Pharma Ltd. (the "Company") (NASDAQ: NTEC ), ... based on its proprietary Accordion Pill platform technology, today ... the United States of 5,025,000 ... public of $6.00 per ordinary share, before underwriting discounts ... offered by the Company.  In addition, the Company has ...
(Date:8/4/2015)... 4, 2015 Transparency Market Research ... Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... market report published by Transparency Market Research " Non-invasive ... Share, Growth, Trends and Forecast 2014 - 2022 ", ...
Breaking Medicine Technology:Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5
... SAN DIEGO, Nov. 4 Orexigen® Therapeutics, Inc. (Nasdaq: ... treatment of obesity, today announced unaudited financial results for ... Three Months Ended September 30, 2009 , ... in cash and cash equivalents and an additional $50.9 ...
... Technologies, manufacturer of custom fluid handling fiber and foam ... a division of UK-based Filtrona plc (Pink Sheets: FLRAF), ... select medical and personal care markets, specifically wound care. ... patent-pending foam-fiber composite consists of a soft, highly absorbent ...
Cached Medicine Technology:Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 2Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 3Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 4Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 5Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 6Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 7Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 8Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 9Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 10Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings 2
(Date:8/4/2015)... ... 2015 , ... How cool is it to check in at your favorite ... "Now" feature will soon allow you to do just that. , Ahhaa is releasing ... the now feature. , Users will soon get to share what inspires them about ...
(Date:8/4/2015)... ... August 04, 2015 , ... World Patent ... Dumbbell Bench Rack, a fitness invention that eliminates the need to have a ... and Fitness Clubs industry is worth $30 billion," says Scott Cooper, CEO and ...
(Date:8/4/2015)... ... 04, 2015 , ... The United Nations Foundation today announced ... Indonesia for a select group of U.S.-based journalists during the week of November ... the International Conference on Family Planning in Bali. , In close coordination ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... An ... found financial incentives to be a viable method for encouraging people to lose weight. ... on the future of their weight loss success, adding a financial incentive to the ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... suffering from underarm sweat. Evolutions Medical & Day Spa in Santa Barbara, CA ... only non-invasive, FDA cleared treatment that permanently eliminates sweat and odor glands in ...
Breaking Medicine News(10 mins):Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3
... ... Hill Village will participate in the first-ever virtual classroom presentation of Mindfulness and Chocolate. ... Internet, will conduct the two-hour session. The class is designed to raise a participant,s ... ...
... ... and Siemens Home Appliance Group,s Protos Stove to local communities living near its Jatropha ... Oil to fuel the stoves. , ... (PRWEB) May 25, 2010 -- Indonesia based PT Waterland International ...
... and acceptance Three new reports describe biomarkers ... excellent and stable allograft function in the absence of ... transplants. Peter Heeger and Bernd Schrppel, at Mount Sinai ... commentary, the importance of these studies and how they ...
... their quality of life, researchers say , MONDAY, May ... of life as being as good as that of ... finding suggests that despite the numerous challenges they face ... social stigma and the effects of medication, children with ...
... a distinct pattern of gene expression in the largest ... rejected the transplant kidneys even though they stopped taking ... recipients who could safely reduce or end use of ... the United States were living with a kidney transplant. ...
... flu shot, expert says , MONDAY, May 24 (HealthDay News) -- ... at high risk of experiencing serious complications for themselves and their ... there has not been much data about the effect of the ... data exists is conflicting. In other pandemic flus -- in 1918 ...
Cached Medicine News:Health News:eMindful Provides a New Twist on Chocolate for Members of Boston's Beacon Hill Village 2Health News:Waterland International Together with Bosch and Siemens Home Appliance Group (BSH) Continue to Help Local Communities in Indonesia 2Health News:Waterland International Together with Bosch and Siemens Home Appliance Group (BSH) Continue to Help Local Communities in Indonesia 3Health News:JCI table of contents: May 24, 2010 2Health News:JCI table of contents: May 24, 2010 3Health News:JCI table of contents: May 24, 2010 4Health News:JCI table of contents: May 24, 2010 5Health News:JCI table of contents: May 24, 2010 6Health News:JCI table of contents: May 24, 2010 7Health News:JCI table of contents: May 24, 2010 8Health News:JCI table of contents: May 24, 2010 9Health News:Children With Epilepsy Feel on Par With Healthy Siblings 2Health News:Gene pattern may identify kidney transplant recipients who don't need life-long anti-rejection drugs 2Health News:Gene pattern may identify kidney transplant recipients who don't need life-long anti-rejection drugs 3Health News:Gene pattern may identify kidney transplant recipients who don't need life-long anti-rejection drugs 4Health News:H1N1 Pandemic Flu Hits Pregnant Women Hard 2
... The Appose Single Use Skin Staple ... tip extractor design that is packaged ... used to remove skin staples. The ... jaws of the extractor under the ...
... Staplers place single staples to close ... lubricant-coated stainless steel; the staplers are ... different skin staplers to meet your ... applications for routine skin closure in ...
... a full-feature skin stapler with a 360° ... improved visibility over existing fixed-head skin stapling ... easier staple placement., ,This Skin Stapler ... designed to deliver rectangular, stainless steel staples ...
... 55 Articulating Linear Staplers are available with ... thick-tissue green instrument (non-reloadable). Each instrument contains ... line., ,Benefits include: , Small profile ... male pelvis. , Articulating head rotates up ...
Medicine Products: